Gelesis IPO

www.gelesis.com

Gelesis is a biotherapeutics company advancing a novel hydrogel platform technology to treat obesity, help with weight management, and other chronic metabolic diseases.

Founded2006
Total Funding to Date$207.14MM
Register for Details

For more details on financing and valuation for Gelesis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Gelesis Ticker Symbol

Gelesis does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Gelesis Stock Price

The stock price for Gelesis will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Gelesis Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/19/2020 Series Growth 3 $801MM $XXX.XX $XXX.XX
2/28/2018 Series Growth 2 $215.68MM $XXX.XX $XXX.XX
12/30/2015 Series Growth $181.84MM $XXX.XX $XXX.XX
3/26/2015 Series A-5 $147.36MM $XXX.XX $XXX.XX
5/16/2014 Series A-4 $33.3MM $XXX.XX $XXX.XX
1/3/2008 Series A-1, A-2, and A-3 $21.45MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Gelesis in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM